A meiotic B-type cyclin selectively drives mitotic progression and fidelity in cancer cells
Cell cycle transitions are driven by cyclins in complex with cyclin-dependent kinases (CDK). Here, we demonstrate that cyclin B3, an evolutionarily divergent B-type cyclin previously thought to function exclusively in female meiosis, is expressed in mitotic cells and interacts with both CDK1 and CDK2. We show that cyclin B3-CDK1/2 is essential for timely mitotic progression by ensuring proper…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
